Breakthrough drug successfully treats hard-to-control high blood pressure
A new drug that significantly lowers "stubborn" blood pressure is on the horizon, following the results of its Phase III clinical trial. The treatment, called baxdrostat, has been hailed as the most promising advance in hypertension management in decades, demonstrating the ability to help patients whose blood pressure remains dangerously high despite standard therapy.
4 Sep 09:03 · New Atlas